Med23 Deficiency Reprograms the Tumor Microenvironment To Promote Lung Tumorigenesis

Researchers utilized well-characterized KrasG12D-driven non-small cell lung cancer mouse model to investigate the role of Mediator complex subunit 23 (MED23) in lung cancer.